Is heart team fundamental to aortic stenosis transcatheter treatment?
作者信息
Rosa Vitor Emer Egypto, Lopes Antônio Sergio de Santis Andrade, Accorsi Tarso Augusto Duenhas, Lemos Neto Pedro Alves, Pomerantzeff Pablo Maria Alberto, Tarasoutchi Flávio
出版信息
Arq Bras Cardiol. 2014 May;102(5):e55-6. doi: 10.5935/abc.20140060.
Abstract
摘要
相似文献
1
Is heart team fundamental to aortic stenosis transcatheter treatment?
Arq Bras Cardiol. 2014 May;102(5):e55-6. doi: 10.5935/abc.20140060.
2
Transatlantic Editorial on transcatheter aortic valve replacement.
Eur J Cardiothorac Surg. 2017 Jul 1;52(1):1-13. doi: 10.1093/ejcts/ezx196.
3
Evolution of Transcatheter Valve Therapy for Aortic Stenosis.
Interv Cardiol Clin. 2018 Oct;7(4):ix. doi: 10.1016/j.iccl.2018.08.007.
4
Carotid-access transcatheter aortic valve replacement in a patient with a previous mitral valve replacement.
J Card Surg. 2015 Mar;30(3):256-9. doi: 10.1111/jocs.12324. Epub 2014 Mar 10.
5
[Interventional therapy of aortic valve stenosis in Germany].
Internist (Berl). 2016 Apr;57(4):304-16. doi: 10.1007/s00108-016-0028-8.
6
At the heart of matters: the role of the heart team in transcatheter aortic valve replacement.
Trends Cardiovasc Med. 2015 Feb;25(2):162-3. doi: 10.1016/j.tcm.2014.11.004. Epub 2014 Nov 15.
7
The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
Eur J Cardiothorac Surg. 2017 Jan;51(1):80-88. doi: 10.1093/ejcts/ezw211. Epub 2016 Aug 30.
8
9
Transcatheter aortic valve replacement: establishing a comprehensive program model for hybrid cardiac catheterization laboratories in the Department of Veterans Affairs.
Dimens Crit Care Nurs. 2014 Sep-Oct;33(5):262-74. doi: 10.1097/DCC.0000000000000069.
10
Transcatheter Aortic Valve Implantation.
Curr Atheroscler Rep. 2016 May;18(5):27. doi: 10.1007/s11883-016-0577-2.
引用本文的文献
1
Update of the Brazilian Guidelines for Valvular Heart Disease - 2020.
Arq Bras Cardiol. 2020 Oct;115(4):720-775. doi: 10.36660/abc.20201047.
本文引用的文献
1
The art of risk stratification in TAVI.
Eur Heart J. 2013 Jul;34(25):1859-61. doi: 10.1093/eurheartj/eht137. Epub 2013 May 12.
2
Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation.
Eur Heart J. 2013 Jul;34(25):1894-905. doi: 10.1093/eurheartj/eht086. Epub 2013 Mar 13.
3
Guidelines on the management of valvular heart disease (version 2012).
Eur Heart J. 2012 Oct;33(19):2451-96. doi: 10.1093/eurheartj/ehs109. Epub 2012 Aug 24.
4
Two-year outcomes after transcatheter or surgical aortic-valve replacement.
N Engl J Med. 2012 May 3;366(18):1686-95. doi: 10.1056/NEJMoa1200384. Epub 2012 Mar 26.
5
EuroSCORE II.
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5. doi: 10.1093/ejcts/ezs043. Epub 2012 Feb 29.
6
[Brazilian Guidelines for Valve Disease - SBC 2011 / I Guideline Inter-American Valve Disease - 2011 SIAC].
Arq Bras Cardiol. 2011;97(5 Suppl 1):1-67. doi: 10.1590/s0066-782x2011002000001.
7
Transcatheter valve therapy a professional society overview from the american college of cardiology foundation and the society of thoracic surgeons.
J Am Coll Cardiol. 2011 Jul 19;58(4):445-55. doi: 10.1016/j.jacc.2011.05.007. Epub 2011 Jun 28.
8
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
N Engl J Med. 2010 Oct 21;363(17):1597-607. doi: 10.1056/NEJMoa1008232. Epub 2010 Sep 22.
9
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery.
Ann Thorac Surg. 2009 Jul;88(1 Suppl):S23-42. doi: 10.1016/j.athoracsur.2009.05.056.
10
Frailty: an emerging geriatric syndrome.
Am J Med. 2007 Sep;120(9):748-53. doi: 10.1016/j.amjmed.2006.10.018.
Zotero 插件